Free Trial

InnovAge (OTCMKTS:INNV) Stock Crosses Below 50-Day Moving Average - Here's Why

InnovAge logo with Medical background

Key Points

  • InnovAge Holding Corp. (OTCMKTS:INNV) shares fell below their 50-day moving average of $3.97, reaching a low of $3.52 before last trading at $3.55.
  • The company's market capitalization stands at $479.30 million with a P/E ratio of -11.45, indicating negative earnings.
  • InnovAge utilizes the PACE approach to provide comprehensive medical and ancillary services aimed at helping seniors live independently.
  • Want stock alerts on InnovAge? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Shares of InnovAge Holding Corp. (OTCMKTS:INNV - Get Free Report) passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $3.97 and traded as low as $3.52. InnovAge shares last traded at $3.55, with a volume of 34,177 shares.

InnovAge Trading Up 3.5%

The business's 50-day moving average price is $3.93 and its two-hundred day moving average price is $3.53. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.57 and a quick ratio of 1.57. The firm has a market cap of $437.44 million, a price-to-earnings ratio of -10.45 and a beta of 0.51.

About InnovAge

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

See Also

Should You Invest $1,000 in InnovAge Right Now?

Before you consider InnovAge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.

While InnovAge currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines